Skip to main content
GENBSector not reported

Generate Biomedicines, Inc. (GENB) Insider Trading

In the last 90 days, 1 Generate Biomedicines, Inc. (GENB) insider reported no open-market purchases and 2 sales totaling $200,735. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Oct 29, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Oct 29, 2026Frances ArnoldDirectorSale11,409$16.19$184,733
Sep 1, 2026Frances ArnoldDirectorSale1,000$16.00$16,002

Common questions

GENB insider trading FAQ

Are GENB insiders buying or selling?
Over the last 90 days, GENB insiders were net sellers, reporting $0.00 of open-market purchases and $200,735 of sales.
When was the last GENB insider purchase?
No open-market insider purchase of Generate Biomedicines, Inc. stock was reported in the last 90 days.
Where does GENB insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Generate Biomedicines, Inc. officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.